As PPARγ agonist thiazolidinediones have been shown to regulate growth and survival in a number of cancer cell lines [10], we designed this study to evaluate the antitumor effects of TGZ on pancreatic cancer cells in vitro and in vivo, and investigated its mechanism of cytotoxicity. Here, PPARG is linked to pancreatic neoplasm.